This inventor holds 5 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2002-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mystic, CT (US) (2002 - 2012)
- Waunakee, WI (US) (2012)
Company Filing History:

Years Active: 2002-2012
Title: Innovative Mind: Michael P. Burns and His Contributions to Bioconversion
Introduction
Michael P. Burns, an inventive mind based in Mystic, Connecticut, is known for his substantial contributions to the field of biochemistry through his innovative patents. With a total of four patents to his name, Burns's work primarily focuses on the stereoselective bioconversion of aliphatic dinitriles, showcasing his expertise in transforming complex chemical compounds into valuable intermediates for medical applications.
Latest Patents
Burns's latest patents revolve around the regio- and stereoselective bioconversion of selected aliphatic dinitriles into corresponding cyanocarboxylic acids. Specifically, he has developed methods for converting 2-isobutyl-succinonitrile into (S)-3 cyano-5-methylhexanoic acid. This particular compound serves as a crucial intermediate in the synthesis of (S)-3(aminomethyl)-5-methylhexanoic acid, commonly known as pregabalin. Pregabalin holds significant importance in the medical field, being used for the treatment and prevention of various cerebral diseases, including seizure disorders, pain management, and psychotic disorders.
Career Highlights
Currently, Michael P. Burns is associated with Pfizer Corporation, wherein he leverages his extensive knowledge and expertise to contribute to groundbreaking developments in biochemistry. His innovative research has not only advanced the understanding of bioconversion processes but has also opened doors for new therapeutic options in medicine.
Collaborations
Throughout his career, Burns has collaborated with talented individuals such as John Wing Wong and Justin K. Weaver, forging a path of collective innovation. These collaborations have enriched the research environment and have fostered a culture of creativity and advancement within their respective projects.
Conclusion
Michael P. Burns exemplifies the spirit of innovation in the realm of biochemistry. His pioneering work on the stereoselective bioconversion of aliphatic dinitriles has significant implications for modern medicine, particularly in developing treatments for debilitating neurological conditions. The journey of creativity and scientific inquiry continues for Burns as he contributes to the ever-evolving landscape of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile